Healthcare Professionals
Female Sexual Dysfunction: Principles of Diagnosis and Therapy
|
|
March 2005, Obstetrical and Gynecological Survey published a Continuing Medical Education (CME) Review Article that acknowledges
the benefits of Zestra(TM) for both arousal and orgasmic difficulties. The objective of the CME Review Article titled "Female Sexual
Dysfunction: Principles of Therapy" is to provide the most current clinical information available to Obstetricians and Gynecologists on
the topic of female sexual dysfunction and the principles of diagnosis and therapy.
The CME Review Article cites a clinical trial conducted by QualiLife Pharmaceuticals titled "Randomized Placebo-Controlled Double Blind,
Crossover Design Trial of the Efficacy and Safety of Zestra for Women in Women With, and Without Female Sexual Arousal Disorder (FSAD)."
The study of 20 women showed improvement in level of desire, arousal, sensation, pleasure and ability to have orgasms in both normal and
FSAD patients using Zestra(TM), as compared with placebo. Zestra(TM) is the only product listed in the CME Review Article that has
published clinical study results and no known negative effects.
View the entire CME - Female Sexual Dysfunction: Principles of Diagnosis and Therapy PDF
|
|
SmartBrief - E-Mail News for Nurse Practitioners
ZestraTM Feminine Arousal Fluid is the "First Line Choice" of Women's Health Professionals. Click here...
HEALTHCARE PROFESSIONALS: Do you have Zestra™ samples and information available for your patients? If not please fax a sample request on your
letterhead to 843.402.0919.
Latest News and Information
Zestra -- First Clinically Proven Arousal Solution for Women -- To Exhibit at The American College of Obstetricians and
Gynecologists ''ACOG'' Annual Conference
|
|
CHARLESTON, S.C.--(BUSINESS WIRE)--May 9, 2005--QualiLife Pharmaceuticals, Inc., a science-driven company focused on developing and
commercializing meaningful consumer products for the sexual health marketplace, will exhibit Zestra(TM) at the upcoming American College
of Obstetricians and Gynecologists Conference ("ACOG"), in San Francisco May 7-11, 2005. Non-prescription Zestra(TM) is the only
clinically proven topical product available for women who experience sexual difficulties.
View the entire release...
|
|
Pharmacy Times - Hot OTC Product
Announcing the New Zestra Retail Packaging.
 View the Pharmacy Times Excerpt
Journal Publications
Clinical Proceedings - Association of Reproductive Health Professionals
|
|
A New View of Women's Sexual Health in Midlife and Beyond
"A botanical feminine massage oil formulated to enhance female sexual pleasure and arousal when applied to the vulva, Zestra was
compared
in a randomized, doubleblind, crossover study with placebo oil in 10 women with and 10 women without female sexual arousal disorder
(FSAD). Both women with and without FSAD showed statistically significant improvements compared with placebo in levels of arousal and
desire, satisfaction with arousal, genital sensation, the ability to have orgasms, and sexual pleasure. A greater response was found in
women with the disorder compared with women who did not complain of arousal problems."
View the entire A New View of Women's Sexual Health in Midlife and Beyond Excerpt
|
|
|
|
Female Sexual Dysfunction - Potential for Pharmacotherapy
"The act of sex includes a woman's sexual self and self-image, intimate relationships, family, society and culture. The complexities of
her
environment, sexual and partner history, past relationships, mental health status, current medical problems and hormonal status all play a role. An
interdisciplinary consensus conference panel expanded the former Diagnostic and Statistical Manual of Mental Disorders-IV classifications of female
sexual dysfunction to include psychogenic and organic causes of desire, arousal, orgasm and sexual pain disorders that cause personal
distress..."
View Excerpts from the Drugs Journal Article
|
|
|
|
Randomized, Placebo-Controlled, Double Blind, Crossover Design Trial of the Efficacy and Safety of Zestra for Women in Women With and
Without Female Sexual Arousal Disorder
Zestra for Women is a botanical feminine massage oil formulated to enhance female sexual pleasure and arousal when applied to the vulva. We conducted
this randomized, double-blinded, crossover study to evaluate the efficacy and safety of Zestra for Women compared to placebo oil in 10 women with and
10 women without female sexual arousal disorder (FSAD) in conditions of home use in conjunction with sexual activities...
Read the abstract
from the 12-page JSMT article
|
|
Clinical Research
RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE BLIND, CROSSOVER DESIGN PILOT TRIAL OF THE EFFICACY AND SAFETY OF ZESTRA™ FOR WOMEN IN WOMEN WITH ,AND
WITHOUT,
FEMALE
SEXUAL AROUSAL DISORDER.
Study Documentation
Slide Presentation (PDF)
THE EFFECT OF ANTIDEPRESSANT USAGE ON THE EFFICACY OF ZESTRA™ FOR
WOMEN IN WOMEN WITH, AND WITHOUT, FEMALE SEXUAL AROUSAL DISORDER.
Study Documentation
Slide Presentation (PDF)
Click here to view all research documentation.
QualiLife has been a proud and supportive sponsor of several conferences dealing with female sexual health.
Click here to learn more...
Featured In:
  
* Click on one of the above logos to view it's article details.
|
|
